Black Diamond Therapeutics (BDTX) Cash & Equivalents (QoQ) (2019 - 2026)

Black Diamond Therapeutics (BDTX) Cash & Equivalents (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Nanobiotix 1,819.54 Bn 1,819.48 Bn -
2 Akari Therapeutics 999.93 Bn 999.93 Bn -
3 BeOne Medicines 473.50 Bn 468.71 Bn 1.35 Bn
4 Vertex Pharmaceuticals 123.06 Bn 115.81 Bn 2.59 Bn
5 Regeneron Pharmaceuticals 71.57 Bn 62.82 Bn 3.31 Bn
6 Belite Bio 62.14 Bn 62.14 Bn -
7 Argenx Se 54.72 Bn 49.54 Bn 1.41 Bn
8 Alnylam Pharmaceuticals 38.24 Bn 35.23 Bn 959.66 Mn
9 Revolution Medicines 36.36 Bn 36.36 Bn -
10 Black Diamond Therapeutics 98.16 Mn -20.10 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 43.26%
Dec 31, 2025 -31.99%
Sep 30, 2025 2.90%
Jun 30, 2025 -69.53%
Mar 31, 2025 170.12%
Dec 31, 2024 55.55%
Sep 30, 2024 -28.61%
Jun 30, 2024 29.07%
Mar 31, 2024 -54.78%
Dec 31, 2023 -3.03%
Sep 30, 2023 38.41%
Jun 30, 2023 7.02%
Mar 31, 2023 14.06%
Dec 31, 2022 -36.41%
Sep 30, 2022 -3.43%
Jun 30, 2022 3.32%
Mar 31, 2022 -17.81%
Dec 31, 2021 41.19%
Sep 30, 2021 24.86%
Jun 30, 2021 164.62%